# Spatial Analysis and Validation of Glioblastoma on 7 T MRI

> **NCT02062372** · NA · TERMINATED · sponsor: **Maastricht Radiation Oncology** · enrollment: 5 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** 7 T MRI
- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT02062372
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-10
- **Primary completion:** 2018-02-05
- **Final completion:** 2018-02-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Expectation that within the set time period insufficient patients will be included, so endpoints will not be achieved
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062372, "Spatial Analysis and Validation of Glioblastoma on 7 T MRI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02062372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*